Atenolol Induced HDL-C Change in the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) Study

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  McDonough, Caitrin W ^a   Gillis, Nancy K ^a   Alsultan, Abdullah ^a   Chang, Shin Wen ^a   Kawaguchi Suzuki, Marina ^a   Lang, Jason E ^b   Shahin, Mohamed Hossam A ^a   Buford, Thomas W ^c   El Rouby, Nihal M ^a   Sá, Ana C C ^a   Langaee, Taimour Y ^a   Gums, John G ^a,c   Chapman, Arlene B ^d   Cooper DeHoff, Rhonda M ^a,c   Turner, Stephen T ^e   Gong, Yan ^a   Johnson, Julie A ^a,c  

^a UNIVERSITY OF FLORIDA   (United States)

^b NEMOURS CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCHLOROTHIAZIDE;

ABCB1 GENE; ADOLESCENT; ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG DOSE TITRATION; DRUG MECHANISM; ESR1 GENE; ETHNICITY; EUROPEAN AMERICAN; FEMALE; FTO GENE; GALNT2 GENE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENE IDENTIFICATION; GENOTYPE; HUMAN; HYPERTENSION; LIPC GENE; LIPOPROTEIN BLOOD LEVEL; MALE; MONOTHERAPY; MULTICENTER STUDY; OPEN STUDY; PHARMACOGENOMICS; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN FUNCTION; RANDOMIZED CONTROLLED TRIAL; SINGLE NUCLEOTIDE POLYMORPHISM; STARD3NL GENE;

ADULT; AFRICAN AMERICANS; ANTIHYPERTENSIVE AGENTS; ATENOLOL; CHOLESTEROL, HDL; ESTROGEN RECEPTOR ALPHA; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HUMANS; HYPERTENSION; LINEAR MODELS; LIPASE; LIPID METABOLISM; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-5; MALE; MEMBRANE PROTEINS; MIDDLE AGED; N-ACETYLGALACTOSAMINYLTRANSFERASES; P-GLYCOPROTEIN; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS;

EID: 84885052632     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076984     Document Type: Article

References (34)

1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, et al. (2013) Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation 127: 143-152. doi:10.1161/CIR.0b013e318282ab8f. PubMed: 23283859.
2. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, et al. (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289: 2560-2572. doi:10.1001/jama.289.19.2560. PubMed: 12748199.
3. Messerli FH, Bangalore S, Julius S, (2008) Risk/benefit assessment of beta-blockers and diuretics precludes their use for first-line therapy in hypertension. Circulation 117: 2706-2715; discussion.
4. Lehtonen A, Marniemi J, (1984) Effect of atenolol on plasma HDL cholesterol subfractions. Atherosclerosis 51: 335-338. doi:10.1016/0021-9150(84)90181-3. PubMed: 6743386.
5. Gordon DJ, Rifkind BM, (1989) High-density lipoprotein--the clinical implications of recent studies. N Engl J Med 321: 1311-1316. doi:10.1056/NEJM198911093211907. PubMed: 2677733.
6. Barter P, Gotto AM, LaRosa JC, Maroni J, Szarek M, et al. (2007) HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med 357: 1301-1310. doi:10.1056/NEJMoa064278. PubMed: 17898099.
7. Jafri H, Alsheikh-Ali AA, Karas RH, (2010) Meta-analysis: statin therapy does not alter the association between low levels of high-density lipoprotein cholesterol and increased cardiovascular risk. Ann Intern Med 153: 800-808. doi:10.7326/0003-4819-153-12-201012210-00006. PubMed: 21173414.
8. Barter PJ, Caulfield M, Eriksson M, Grundy SM, Kastelein JJ, et al. (2007) Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med 357: 2109-2122. doi:10.1056/NEJMoa0706628. PubMed: 17984165.
9. Boden WE, Probstfield JL, Anderson T, Chaitman BR, Desvignes-Nickens P, et al. (2011) Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med 365: 2255-2267. doi:10.1056/NEJMoa1107579. PubMed: 22085343.
10. Weiss LA, Pan L, Abney M, Ober C, (2006) The sex-specific genetic architecture of quantitative traits in humans. Nat Genet 38: 218-222. doi:10.1038/ng1726. PubMed: 16429159.
11. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, et al. (2010) Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466: 707-713. doi:10.1038/nature09270. PubMed: 20686565.
12. Keating BJ, Tischfield S, Murray SS, Bhangale T, Price TS, et al. (2008) Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies. PLOS ONE 3: e3583. doi:10.1371/journal.pone.0003583. PubMed: 18974833.
13. Johnson JA, Boerwinkle E, Zineh I, Chapman AB, Bailey K, et al. (2009) Pharmacogenomics of antihypertensive drugs: rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study. Am Heart J 157: 442-449. doi:10.1016/j.ahj.2008.11.018. PubMed: 19249413.
14. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575. doi:10.1086/519795. PubMed: 17701901.
15. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, et al. (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38: 904-909. doi:10.1038/ng1847. PubMed: 16862161.
16. Saxena R, Elbers CC, Guo Y, Peter I, Gaunt TR, et al. (2012) Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci. Am J Hum Genet 90: 410-425. doi:10.1016/j.ajhg.2011.12.022. PubMed: 22325160.
17. Yuan HY, Chiou JJ, Tseng WH, Liu CH, Liu CK, et al. (2006) FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res 34: W635-W641. doi:10.1093/nar/gkj469. PubMed: 16845089.
18. Chelala C, Khan A, Lemoine NR, (2009) SNPnexus: a web database for functional annotation of newly discovered and public domain single nucleotide polymorphisms. Bioinformatics 25: 655-661. doi:10.1093/bioinformatics/btn653. PubMed: 19098027.
19. Ge D, Zhang K, Need AC, Martin O, Fellay J, et al. (2008) WGAViewer: software for genomic annotation of whole genome association studies. Genome Res 18: 640-643. doi:10.1101/gr.071571.107. PubMed: 18256235.
20. Barrett JC, Fry B, Maller J, Daly MJ, (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265. doi:10.1093/bioinformatics/bth457. PubMed: 15297300.
21. Pruim RJ, Welch RP, Sanna S, Teslovich TM, Chines PS, et al. (2010) LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 26: 2336-2337. doi:10.1093/bioinformatics/btq419. PubMed: 20634204.
22. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. doi:10.1006/meth.2001.1262. PubMed: 11846609.
23. Willer CJ, Sanna S, Jackson AU, Scuteri A, Bonnycastle LL, et al. (2008) Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 40: 161-169. doi:10.1038/ng.76. PubMed: 18193043.
24. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, et al. (2007) A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316: 889-894. doi:10.1126/science.1141634. PubMed: 17434869.
25. Asselbergs FW, Guo Y, van Iperen EP, Sivapalaratnam S, Tragante V, et al. (2012) Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. Am J Hum Genet 91: 823-838. doi:10.1016/j.ajhg.2012.08.032. PubMed: 23063622.
26. Fiegenbaum M, da Silveira FR, Van der Sand CR, Van der Sand LC, Ferreira ME, et al. (2005) The role of common variants of ABCB1, CYP3A4, and CYP3A5 genes in lipid-lowering efficacy and safety of simvastatin treatment. Clin Pharmacol Ther 78: 551-558. doi:10.1016/j.clpt.2005.08.003. PubMed: 16321621.
27. Fujino T, Asaba H, Kang MJ, Ikeda Y, Sone H, et al. (2003) Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion. Proc Natl Acad Sci U S A 100: 229-234. doi:10.1073/pnas.0133792100. PubMed: 12509515.
28. Alpy F, Tomasetto C, (2006) MLN64 and MENTHO, two mediators of endosomal cholesterol transport. Biochem Soc Trans 34: 343-345. doi:10.1042/BST0340343. PubMed: 16709157.
29. Kajinami K, Brousseau ME, Lamon-Fava S, Ordovas JM, Schaefer EJ, (2005) Gender-specific effects of estrogen receptor alpha gene haplotype on high-density lipoprotein cholesterol response to atorvastatin: interaction with apolipoprotein AI gene polymorphism. Atherosclerosis 178: 331-338. doi:10.1016/j.atherosclerosis.2004.08.034. PubMed: 15694942.
30. Kingsley DM, Kozarsky KF, Hobbie L, Krieger M, (1986) Reversible defects in O-linked glycosylation and LDL receptor expression in a UDP-Gal/UDP-GalNAc 4-epimerase deficient mutant. Cell 44: 749-759. doi:10.1016/0092-8674(86)90841-X. PubMed: 3948246.
31. Loos RJ, Bouchard C, (2008) FTO: the first gene contributing to common forms of human obesity. Obes Rev 9: 246-250. doi:10.1111/j.1467-789X.2008.00481.x. PubMed: 18373508.
32. Mahungu TW, Nair D, Smith CJ, Egan D, Youle M, et al. (2009) The relationships of ABCB1 3435C>T and CYP2B6 516GT with high-density lipoprotein cholesterol in HIV-infected patients receiving Efavirenz. Clin Pharmacol Ther 86: 204-211. doi:10.1038/clpt.2009.78. PubMed: 19474786.
33. Schmitz G, Grandl M, (2009) The molecular mechanisms of HDL and associated vesicular trafficking mechanisms to mediate cellular lipid homeostasis. Arterioscler Thromb Vasc Biol 29: 1718-1722. doi:10.1161/ATVBAHA.108.179507. PubMed: 19846837.
34. Keene KL, Mychaleckyj JC, Smith SG, Leak TS, Perlegas PS, et al. (2008) Comprehensive evaluation of the estrogen receptor alpha gene reveals further evidence for association with type 2 diabetes enriched for nephropathy in an African American population. Hum Genet 123: 333-341. doi:10.1007/s00439-008-0482-z. PubMed: 18305958.